Effect of marathon run on serum IGF-I and IGF-binding protein 1 and 3 levels

Journal of Applied Physiology

Volumn 80, Issue 3, 1996, Pages 760-764

  Koistinen, Hannu ^a   Koistinen, Riitta ^a   Selenius, Linnea ^a   Ylikorkala, Olavi ^a   Seppälä, Markku ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

exercise; insulin; insulin like growth factor I; insulin like growth factor binding protein

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE UTILIZATION; GROWTH HORMONE RELEASE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; MALE; MARATHON RUNNER; MUSCLE METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL; RUNNING;

EID: 0029968195     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1996.80.3.760     Document Type: Article

References (39)

1. Bang, P., J. Brandt, M. Degerblad, G. Enberg, L. Kaijser, M. Thóren, and K. Hall. Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency. Eur. J. Clin. Invest. 20: 285-292, 1990.
2. Bar, R. S., D. R. Clemmons, M. Boes, W. H. Busby, B. A. Booth, B. L. Dake, and A. Sandra. Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like growth factor binding proteins in the rat heart. Endocrinology 127: 1078-1086, 1990.
3. Baxter, R. C. The somatomedins: insulin-like growth factors. Adv. Clin. Chem. 25: 49-115, 1986.
4. Bloom, S. R., R. H. Johnson, D. M. Park, M. J. Rennie, and W. R. Sulaiman. Differences in the metabolic and hormonal response to exercise between racing cyclists and untrained individuals. J. Physiol. Lond. 258: 1-18, 1976.
5. Blum, W. F., K. Albertsson-Wikland, S. Rosberg, and M. B. Ranke. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J. Clin. Endocrinol. Metab. 76: 1610-1616, 1993.
6. Clemmons, D. R., C. Camacho-Hubuer, J. I. Jones, R. H. McCusker, and W. H. Busby, Jr. Insulin-like growth factor binding proteins: mechanism of action at the cellular level. In: Modern Concepts of Insulin-like Growth Factors, edited by E. M. Spencer. New York: Elsevier Science, 1991, p. 475-486.
7. Cohen, K. L., and S. P. Nissley. The serum half-life of somatomedin activity: evidence for growth hormone-dependence. Acta Endocrinol. 83: 243-258, 1976.
8. Cuneo, R. C., and J. D. Wallace. Growth hormone, insulin-like growth factors and sport. Endocrinol. Metab. 1: 3-13, 1994.
9. Daughaday, W. H., and P. Rotwein. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr. Rev. 10: 68-91, 1989.
10. Dill, D. B., and D. L. Costill. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J. Appl. Physiol. 37: 247-248, 1974.
11. Frystyk, J., C. Skjærbæk, B. Dinesen, and H. Ørskov. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 348: 185-191, 1994.
12. Hintz, R. L., P. Liu, R. G. Rosenfeld, and S. F. Kemp. Plasma somatomedin binding proteins in hypopituitarism: changes during growth hormone therapy. J. Clin. Endocrinol. Metab. 53: 100-104, 1981.
13. Holly, J. M. P., D. C. P. Claffey, S. C. Cwyfan-Hughes, V. J. Frost, and M. E. Yateman. Proteases acting on IGFBPs: their occurrence and physiological significance. Growth Regul. 3: 88-91, 1993.
14. Hopkins, N. J., P. M. Jakeman, S. Cwyfan-Hughes, and J. M. P. Holly. Changes in circulating insulin-like growth factor-binding protein-1 (IGFBP-1) during prolonged exercise: effect of carbohydrate feeding. J. Clin. Endocrinol. Metab. 79: 1887-1890, 1994.
15. Humbel, R. E. Insulin-like growth factors I and II. Eur. J. Biochem. 190: 445-462, 1990.
16. Hunter, W. M., C. C. Fonseka, and R. Passmore. The role of growth hormone in the mobilization of fuel for muscular exercise. Q. J. Exp. Physiol. 50: 406-416, 1965.
17. Jahreis, G., V. Hesse, H. E. Schmidt, and J. Scheibe. Effects of endurance exercise on somatomedin-C/insulin-like growth factor I concentration in male and female runners. Exp. Clin. Endocrinol. 94: 88-96, 1989.
18. Jorgensen, J. O. L., W. F. Blum, N. Møller, M. B. Ranke, and J. S. Christiansen. Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. J. Clin. Endocrinol. Metab. 72: 582-587, 1991.
19. Köhler, G., and C. Milstein. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature Lond. 256: 495-497, 1975.
20. Koistinen, R., M.-L. Huhtala, U.-H. Stenman, and M. Seppälä. Purification of placental protein PP12 from human amniotic fluid and its comparison with PP12 from placenta by immunological, physicochemical and somatomedin-binding properties. Clin. Chim. Acta 164: 293-303, 1987.
21. Koistinen, H., M. Seppälä, and R. Koistinen. Different forms of insulin-like growth factor-binding protein-3 detected in serum and seminal plasma by immunofluorometric assay with monoclonal antibodies. Clin. Chem. 40: 531-536, 1994.
22. Koistinen, R., U.-H. Stenman, H. Alfthan, and M. Seppälä. Time-resolved immunofluorometric assay of 34-kDa somatomedin-binding protein. Clin. Chem. 33: 1126-1128, 1987.
23. Kraemer, W. J. Endocrine responses to resistance exercise. Med. Sci. Sports Exercise 20: S152-S157, 1988.
24. Kraemer, R. R., J. L. Kilgore, G. R. Kraemer, and V. D. Castracane. Growth hormone, IGF-I, and testosterone responses to resistive exercise. Med. Sci. Sports Exercise 24: 1346-1352, 1992.
25. Lamson, G., L. C. Giudice, and R. G. Rosenfeld. A simple assay for proteolysis of IGFBP-3. J. Clin. Endocrinol. Metab. 72: 1391-1393, 1991.
26. Leahy, J. L., and K. M. Vandekerkhove. Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology 126: 1593-1598, 1990.
27. Lee, P. D. K., C. A. Conover, and D. R. Powell. Regulation and function of insulin-like growth factor-binding protein-1. Proc. Soc. Exp. Biol. Med. 204: 4-29, 1993.
28. Malm, H. T., H. M. Ronni-Sivula, L. U. Viinikka, and O. R. Ylikorkala. Marathon running accompanied by transient decreases in urinary calcium and serum osteocalcin levels. Calcif. Tissue Int. 52: 209-211, 1993.
29. Martin, J. L., and R. C. Baxter. Insulin-like growth factor binding protein-3: biochemistry and physiology. Growth Regul. 2: 88-99, 1992.
30. McCann, M., J. A. Brasel, and D. M. Cooper. Effect of brief exercise on circulating IGF BP-3 in healthy humans. Program 76th Annu. Meet. Endocr. Soc. Anaheim CA 1994, Abstract no. 561.
31. Shimasaki, S., and N. Ling. Identification and molecular characterization of insulin-like growth factor-binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog. Growth. Factor Res. 3: 243-266, 1991.
32. Smith, A. T., D. R. Clemmons, L. E. Underwood, V. Ben-Ezra, and R. McMurray. The effect of exercise on plasma somatomedin-C/insulinlike growth factor I concentrations. Metabolism 36: 533-537, 1987.
33. Suikkari, A.-M., V. Koivisto, E.-M. Rutanen, H. Yki-Järvinen, S.-L. Karonen, and M. Seppälä. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J. Clin. Endocrinol. Metab. 66: 266-272, 1988.
34. Suikkari, A.-M., T. Sane, M. Seppälä, H. Yki-Järvinen, S.-L. Karonen, and V. A. Koivisto. Prolonged exercise increases serum insulin-like growth factor-binding protein concentrations. J. Clin. Endocrinol. Metab. 68: 141-144, 1989.
35. Van Schravendijk, C. F. H., L. Heylen, J. L. Van den Brande, and D. G. Pipeleers. Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells. Diabetologia 33: 649-653, 1990.
36. Wilmore, D. W. Catabolic illness. Strategies for enhancing recovery. N. Engl. J. Med. 325: 695-702, 1991.
37. Wirth, A., C. Diehm, H. Mayer, H. Mörl, I. Vogel, P. Björntorp, and G. Schlierf. Plasma C-peptide and insulin in trained and untrained subjects. J. Appl. Physiol. 50: 71-77, 1981.
38. Yeoh, S. I., and R. C. Baxter. Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma. Acta Endocrinol. 119: 465-473, 1988.
39. Zapf, J., M. Waldvogel, and E. R. Froesch. Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein. Arch. Biochem. Biophys. 168:638-645, 1975.